Lincoln Pharmaceuticals’ board to consider merger of Lincoln Parenteral

11 Sep 2019 Evaluate

Lincoln Pharmaceuticals' board is planning to consider and approve draft scheme of amalgamation of its subsidiary -- Lincoln Parenteral (The Transferor Company) with Lincoln Pharmaceuticals (The Transferee Company). The company’s board at their meeting to be held on September 19, 2019, to consider the same.

Lincoln Pharmaceuticals is engaged in the manufacture and marketing of affordable therapeutic products. The product range of the company includes Tablets, Capsules, Injectable, Syrups and Ointments.

Lincoln Pharma Share Price

459.90 7.05 (1.56%)
22-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1634.40
Dr. Reddys Lab 1217.15
Cipla 1371.55
Zydus Lifesciences 884.85
Lupin 2165.05
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×